It has received FDA approval for weight loss and is recognized for its effectiveness in reducing body mass and improving metabolic health
Unlike older GLP-1 medications that target only one hormone, tirzepatide is the first dual GLP-1 (glucagon-like peptide 1) and GIP receptor agonist that offers greater benefits, including stronger appetite suppression, deeper metabolic changes, and more significant weight loss
Together, these elements create a synergistic formula that aims for gradual, steady improvements rather than quick but unsustainable results
At Klinic in Sioux Falls, South Dakota, we frequently receive questions like "Does insurance cover semaglutide?" Coverage varies by specific plans, but several major insurance companies now acknowledge semaglutide as vital for weight management
Its one of those foundational steps where a small miscalculation can have a cascading effect on your results, potentially invalidating weeks or even months of work
